DoD Peer Reviewed Medical Clinical Trial Award
The PRMRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on a disease or condition addressed in at least one of the Congressionally directed FY14 PRMRP Topic Areas. See Program Announcement for Topic Areas. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials to demonstrate feasibility or inform the design of more advanced trials (e.g., pilot, first in human, Phase 0), through large-scale trials to determine efficacy in relevant patient populations. All studies must be responsive to the health care needs of the military service members, Veterans, and/or beneficiaries; however, the use of military or Veteran populations is not required.
Office: U.S. Army Medical Research Acquisition Activity
